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Abstract
Background: Avian pathogenic Escherichia coli (APEC) is detrimental to poultry health and its zoonotic potential is
a food safety concern. Regulation of antimicrobials in food-production animals has put greater focus on enhancing
host resistance to bacterial infections through genetics. To better define effective mechanism of host resistance,
global gene expression in the spleen of chickens, harvested at two times post-infection (PI) with APEC, was
measured using microarray technology, in a design that will enable investigation of effects of vaccination,
challenge, and pathology level.
Results: There were 1,101 genes significantly differentially expressed between severely infected and non-infected
groups on day 1 PI and 1,723 on day 5 PI. Very little difference was seen between mildly infected and non-infected
groups on either time point. Between birds exhibiting mild and severe pathology, there were 2 significantly
differentially expressed genes on day 1 PI and 799 on day 5 PI. Groups with greater pathology had more genes
with increased expression than decreased expression levels. Several predominate immune pathways, Toll-like
receptor, Jak-STAT, and cytokine signaling, were represented between challenged and non-challenged groups.
Vaccination had, surprisingly, no detectible effect on gene expression, although it significantly protected the birds
from observable gross lesions. Functional characterization of significantly expressed genes revealed unique gene
ontology classifications during each time point, with many unique to a particular treatment or class contrast.
Conclusions: More severe pathology caused by APEC infection was associated with a high level of gene
expression differences and increase in gene expression levels. Many of the significantly differentially expressed
genes were unique to a particular treatment, pathology level or time point. The present study not only investigates
the transcriptomic regulations of APEC infection, but also the degree of pathology associated with that infection.
This study will allow for greater discovery into host mechanisms for disease resistance, providing targets for marker
assisted selection and advanced drug development.
Background
Maintaining proper food-animal health is important
from an animal welfare, animal production and food
safety standpoint. Avian pathogenic Escherichia coli
(APEC) are a group of extraintestinal E. coli that com-
monly infect poultry. Infection can lead to colibacillosis,
a disease that can be localized or systemic, with the
more acute and serious forms ending in septicemia and
death [1,2]. Colibacillosis is one of the most frequent
diseases in poultry resulting in mortality losses at all
stages of life and decreased production efficiency in
older birds [1,3]. Mortality, decreased production and
condemnation of contaminated product may result in
significant economic losses to the poultry industry
worldwide [1,2,4,5].
APEC can enter the food supply though contaminated
eggs and meat [2,5,6], generating a path for human
exposure. APEC has zoonotic potential, demonstrated
by common virulence factors [7,8], genome similarities
to human extraintestinal E. coli [9], and capacity to
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been implicated as a possible source of E. coli responsi-
ble for urinary tract infections and meningitis in
humans [8,11].
There is increasing pressure to reduce antimicrobial
usage in livestock production. Other methods to main-
tain healthy, disease-free populations, such as enhanced
host genetic resistance, have become a topic of great
interest. Previous research has demonstrated the poten-
tial for genetic resistance to disease in poultry [12,13].
Greater understanding of host response to infection and
resulting pathology will allow researchers to identify the
genes that best convey protection.
The spleen is involved in both the humoral and cellu-
lar immune responses through its role in the generation,
maturation and storage of lymphocytes [14,15]. Gene
expression in the chicken spleen is commonly used as
an indicator of immune response [16,17]. Here, we char-
a c t e r i z et h ed i f f e r e n c e si ns p l e n i cg e n ee x p r e s s i o np r o -
files between birds with mild and severe pathology, and
of differing vaccination status over two time points in
order to identify host traits that are associated with coli-
bacillosis resistance.
Methods
Animals
In six replicates, 120 male non-vaccinated commercial
broiler chicks were used at 1 day of age from a local
hatchery (total n = 720). Birds were reared on wire-
floored cages with ad libitum access to food and water,
and a 22:2 hour light:dark cycle for the first 15 days and
a 16:8 hour cycle thereafter. Half of the chicks were vac-
cinated with the increased serum survival protein (Iss)
vaccine [18], given intramuscularly, at a dose of 0.5 ml/
bird, containing 2 μg of vaccine and 50 μgo fQ u i lA
adjuvant in phosphate buffered saline (PBS) at 2 weeks
of age. Non-vaccinated birds received 50 μgo fQ u i lA
adjuvant in 0.5 ml PBS at 2 weeks of age via the same
route. The Iss vaccine is generated from a recombinant
Iss protein fused to glutathione S-transferase (GST). iss
is a gene encoding the increased serum survival outer
membrane protein that is common in many APEC sero-
t y p e s[ 1 9 ] .A t4w e e k so fa g e ,c h i c k sw e r ec h a l l e n g e d
with 0.1 ml containing 10
8 colony forming units of
APEC O1, or PBS, by the intra-air sac route into the left
thoracic air sac. Birds were euthanized and necropsied
at 2 time points, 1 day and 5 days post-challenge, using
half of the birds on each day. All animal research proto-
cols were approved by the Iowa State University Institu-
tional Animal Care and Use Committee.
Lesion scoring
At necropsy, lesions were characterized and scores
assigned for 3 internal tissues, air sacs, pericardium and
liver, as described by Peighambari et al. [20]. Air sacs
had a score range of 0 to 3, pericardium and liver had a
score range of 0 to 2. A total lesion score was generated
from the summation of lesion scores from each of the 3
t i s s u e s ,w i t hs c o r e sr a n g i n gf r o m0t o7 .W i t h i ne a c h
experimental replicate, the birds with the highest and
lowest total lesion scores were designated as having
mild or severe lesions. Birds with mild pathology had
scores ranging from 0 to 2 with an average of 0.375
while those with severe pathology had scores ranging
from 4 to 7 with an average of 6.125. Birds from the
vaccinated, challenged group were not further subdi-
vided by pathology and a bird with an average total
lesion score for that day and experimental replicate
were selected for analysis. Treatment groups are abbre-
viated by vaccination status (V for vaccinated or NV for
non-vaccinated), challenge status (C for challenged or
NC for non-challenged), day of necropsy (D1 for 1 day
post challenge or D5 for 5 days post challenge), and,
where utilized, pathology (M for mild or S for severe).
Bacteria
APEC O1 strain (O1:K1:H7) was previously isolated
from the lung of a turkey that died due to colisepticemia
(NCBI Reference Sequence: NC_008563.1). It has been
fully characterized and its genomic sequence is the only
total APEC sequence presently in the public domain [9].
I tw a ss t o r e di nB r a i nH e a r tI n f u s i o n( B H I )b r o t hw i t h
10% glycerol at -80°C. Two days prior to bacterial chal-
lenge, APEC O1 culture was streaked on Luria Bertani
(LB) agar and incubated overnight at 37°C. After incuba-
tion, 10 ml of LB broth was inoculated with an isolated
colony of APEC O1 from LB agar and incubated over-
night at 37°C with shaking. On the day of challenge, the
bacteria were pelleted by centrifugation at 5000 g for 15
minutes and the bacterial pellet washed 3 times with
PBS. Bacteria were enumerated based on spectrometric
reading at 600 nm, then the inoculum was adjusted to
the desired bacterial concentration in PBS. Counts were
confirmed through serial dilution plating of the inocula
onto MacConkey agar overnight.
Splenic RNA isolation
One sample from each of the 10 treatment groups, over
4 replicates, was selected for RNA isolation and micro-
array analysis. Spleen tissue was removed, diced and
placed into 3.5 ml of RNAlater (Ambion, AM7021). Tis-
sues were kept at 4°C for 7 days, then excess RNAlater
was poured off, tissue transferred to 1.5 ml tube and
stored in -80°C freezer. Isolation of RNA from spleen
samples was performed using the Ambion MagMAX-96
for Microarrays Kit (AM1839) (Applied Biosystems, Fos-
ter City, CA). For each sample, 25 to 30 mg of tissue
was placed into 600 μL of TRI Reagent Solution
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Page 2 of 13(Ambion). Tissues were then homogenized in the TRI
Reagent. Following homogenization, 300 μL of homoge-
nate was processed according to manufacturer’si n s t r u c -
tions, using the Spin Procedure. Total RNA was eluted
using 50 μL of Elution Buffer and stored at -80°C. Qual-
ity and quantity of total RNA was assessed by Nanodrop
(Thermo Scientific) and agarose gel electrophoresis.
Across all 40 samples, the average 260/280 ratio was
2.06 with a standard deviation of 0.055. For 12 random
samples, RNA Integrity Numbers were measured using
Agilent Bioanalyzer 2100 (Agilent Technologies, Santa
Clara, CA). An average RIN of 9.21 was achieved across
all 12 samples.
Microarray experiments
Four hundred nanograms of RNA was reverse tran-
scribed into cDNA. During reverse transcription, a T7
promoter primer region was included into the cDNA.
The cDNA was then transcribed back into cRNA, using
T7 RNA polymerase, labeled with either Cy3 or Cy5
dye. The labeled cRNA was then purified using Qiagen
RNeasy Mini Kit (Qiagen Inc., Valencia, CA). Labeled
samples were assessed by Nanodrop for sufficient quan-
tity and a minimum specificity of 8, where specificity is
the concentration of the dye (pmol/μg) times 1000
divided by the concentration of the cRNA (ng/μL).
Each labeled dye (825 ng) was hybridized to Agilent 4
× 44 Chicken Microarray [21] for 17 hours at 65°C.
Samples were arranged in a reference design, using the
NV-NC-D1 sample from each experimental replicate as
the reference to which all other samples within the
replicate were hybridized. After hybridization, slides
were washed using commercial Agilent Wash Buffer and
Stabilization and Drying Buffer (Agilent Technologies,
Santa Clara, CA) and scanned using GenePix 4100A
scanner (Molecular Devices Inc., Sunnyvale, CA)
Microarray analysis
Median signal intensities for each spot were back-
ground-corrected and log-transformed. The Locally
Weighted Scatterplot Smoothing (LOWESS) procedure
was used to correct the intensity-dependent dye bias for
each 2-color array [22]. All technical control spots and
any genes exhibiting an average signal to noise ratio
(SNR) less than 3 over all 36 arrays were removed from
analysis, where SNR is calculated as (median foreground
- median background)/background SD for each dye.
Likelihood ratio tests were conducted in R to determine
the necessity of including random effects of array posi-
tion, slide and experimental replicate in the model. The
results of these tests showed no evidence of the pre-
sence of array position or slide effects and therefore
only experimental replicate was included as a random
effect. Treatment means were parameterized (Table 1)
and estimated by fitting a linear mixed model to the dif-
ference of normalized signal intensities between the Cy3
and Cy5 channels for each array. The fixed effects of the
linear mixed model include the effects of challenge, vac-
cination, severity (mild or severe), time point and inter-
actions among them using the parameterization shown
in Table 1. P values were obtained for all contrasts of
interest and converted to q-values for false discovery
rate control using the R package q-value that imple-
ments the method proposed by Storey and Tibshirani
[23]. The data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus (GEO)
[24,25] and are accessible through GEO Platform acces-
sion number GPL6413 and Series accession number
GSE25511 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE25511).
Functional analysis of biological processes category
was carried out using the Database for Annotation,
Visualization and Integrated Discovery (DAVID) [26,27].
Lists of significant genes were analyzed against the back-
ground of all 24,851 genes included for further study.
Quantitative PCR
Ten genes, interleukin 1 beta, interleukin 6, avian beta-
defensin 2, avian beta-defensin 6, avian beta-defensin 7,
interferon gamma, toll-like receptor 2-type I, toll-like
receptor 4, myeloid differentiation protein 2,a n dinter-
leukin receptor 1-type II were utilized to validate micro-
array results. Genes were selected based on their
functions in immune response and significance within
microarray results. Primer sequences are listed in Addi-
tional File 1. New primer sequences were designed
using sequences from NCBI and PRIMER3 [28]. Indivi-
dual spleen samples were run in triplicate, with each tri-
plicate randomly distributed on the 96-well plate. RNA
was quantified using QuantiTect SYBR Green kit (Qia-
gen Inc., Valencia, CA) as previously described by Red-
mond et al. [16]. Cycle threshold (Ct) values were
recorded for each sample. Ct values were adjusted for
Table 1 Parameterization of treatment groups
Group Parameterization
NV-NC-D1 μ
NV-NC-D5 μ + τ1
NV-C-D1-M μ + b
NV-C-D5-M μ + b + l
NV-C-D1-S μ + b + g
NV-C-D5-S μ + b + l + g + θ
V-NC-D1 μ + a
V-NC-D5 μ + a + τ2
V-C-D1 μ + a + b + 
V-C-D5 μ + a + b +  + τ3
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Page 3 of 13starting concentration and reaction efficiency using the
formula: 40 - (Sample Mean Ct Target + (Median 28S -
Sample Mean 28S) * (Slope Target/Slope 28S)). Values
were analyzed using the Fit Model procedure in JMP
software (SAS Institute Inc., Cary, NC). Contrasts with
significant differential expression in microarray analysis
had fold change compared to qPCR results.
Results
Microarray
Ten groups were generated by dividing birds into vacci-
nated (V) and non-vaccinated (NV), challenged (C) and
non-challenged (NC), sampled on 1 (D1) or 5 (D5) days
post challenge, and the non-vaccinated challenged birds
on both days were subdivided into mild (M) and severe
(S) pathology (Figure 1). Birds were assigned to vaccina-
tion, challenge and time post-harvest groups ap r i o r i ,
and to pathology severity groups ap o s t e r i o r i . Samples
from 40 individual birds (four biological replicates from
each of 10 treatment groups) were used for gene expres-
sion study. After the removal of genes with low signal to
noise ratio, 24,851 genes were included for further ana-
lysis. There was no detectible vaccination effect on
spleen gene expression levels. Vaccination status had,
however, a significant impact on total lesion score on
d a y1( F i g u r e2 a )a n dd a y5( F i g u r e2 b )( P value <
0.001), reducing the total lesions observed in vaccinated
birds. The number of significantly differentially
expressed (DE) genes (q-value < 0.05) between treat-
ment groups and NV-NC control groups were analyzed
(Figure 3a). There were a large number of DE genes
between NV-C severe and NV-NC control groups on
day 1 (n = 1,101) and day 5 (n = 1,723). There were few
DE genes between NV-C mild and NV-NC control
groups on day 1 (n = 29) and (n = 0) on day 5. The
change in gene expression over the two post-infection
days was analyzed within each treatment group (Figure
3b). The NV-C severe group showed the most difference
between the two days with 248 DE genes. The differ-
ences between the two pathologies, NV-C mild and NV-
C severe, were analyzed (Figure 3c). More DE genes
were seen on day 5 (n = 799) between pathologies than
on day 1, (n = 2).
Direction and degree of difference between treatment
groups was analyzed (Figure 4). Given a threshold of a
minimum fold change of 1.5, there was a greater num-
ber of up-regulated genes due to increased pathology
than the number of down-regulated genes. Visual com-
parison between multiple contrasts was generated.
When comparing the change over time for all treatment
groups, the NV-C mild pathology group clustered with
both the NV-NC and V-NC groups; the NV-C severe
pathology group and the V-C group clustered together
(Figure 5). When comparing each treatment group to
the NV-NC control group on each day, the NV-C mild
group on day 5 clustered with the V-NC groups, while
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Figure 1 Experimental design. Flow chart of experimental design and 10 treatment groups showing how bird numbers within each replicate
were placed into each of the 10 treatment groups.
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Page 5 of 13the NV-C mild group on day 1 clustered with the chal-
lenged groups (Figure 6).
Gene ontology analysis
All contrasts in which there were sufficient DE genes
(n > 29) were further analyzed for common biological
processes (BP). For GO analysis, seven contrasts had
significantly enriched BP terms. There were 156
unique BP terms, of which 95 were uniquely repre-
sented once across all 7 contrasts (See Additional
F i l e s2 ,3 ,4 ,5 ,6 ,7 ,8 ) .M a n yo ft h er e p e a t e db i o l o g i -
cal process terms focused on white blood cell regula-
tion along with defense/immune response to bacteria,
and metabolic processes. The groups with the highest
number of DE genes had the most biological terms
common to these genes (Table 2). In contrasting NV-
C severe and NV-NC control groups, on day 1 PI
many biological processes were centered around
immune and defense response, while day 5 PI heavily
focused on regulation of white blood cells. The two
most influenced KEGG pathways were the Jak-STAT
signaling pathway and the cytokine-cytokine receptor
interaction pathway, which occurred in the contrast
between NC-C severe and NV-NC control on day 5
and in the contrast between NV-C severe and NV-C
mild on day 5.
Quantitative PCR validation
Quantitative real time PCR (qPCR) was carried out on
ten significantly DE genes, using a subset of the same
RNA samples used for microarray analysis, to confirm
the results seen on the microarray. Samples from vacci-
nated groups were not included in qPCR analysis due to
no DE genes from vaccination effect, allowing analysis
of 24 samples (4 replicates from 6 treatment groups). A
normalizer gene, ribosomal 28S, was used to correct for
starting template amount. Results from qPCR validation
show general agreement with microarray results in
direction of expression and significance (Table 3).
Discussion
Experimental design
This was a novel experimental design, allowing a contrast
not only between challenged and non-challenged indivi-
duals, but also varying degrees of pathology. The large
number of birds allotted into the challenged groups
allowed the identification of a sufficient spread of lesion
scores to separate pathology groups (Figure 1). These
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Page 6 of 13commercial birds were raised in a homogenous environ-
ment and exhibited a large spread in pathological
response, suggesting that a mechanism other than envir-
onment, genetic variation, is responsible for the resistant
or susceptible phenotypes and is available to select upon.
The common reference design was selected for this
microarray experiment. Although there are loop designs
that could gain some efficiency for some contrasts, the
efficiency gain of could be eliminated in the instance of
a loss of a microarray slide. This is because a rather big
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Page 7 of 13loop would be needed for our study of 10 treatment
groups and the design of the microarray slide with 4
arrays per 1 slide would result in a large loss of data if a
s l i d ew e r et of a i l .H o w e v e r ,reference design is very
robust in this sense. Statistical calculation also shows
that the reference design using the most naïve group,
the NC-NV-D1 group, as the reference provides com-
parable variance estimates for our contrasts of interest
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Page 8 of 13with the loop design. The common reference design was
suggested by Dobbin and Simon [29] because it pro-
duces better results than does a loop design for multiple
comparisons and clustering analysis, both of which were
applied in data analysis.
Differential gene expression
Surprisingly, there was no significant vaccination effect
on gene expression in the spleen. The vaccine, however,
was clearly effective in protecting the chicks, as evi-
denced by the lesion scores. There are several variables
that could contribute to no detection of DE genes in
response to vaccination: statistical power, the tissue
examined or the timeframe selected, in regard to age
vaccinated, age challenged, and time points tissues were
collected. Fold change calculations of these non-signifi-
cant genes reveal few changes of 2 fold or greater, sug-
gesting that inter-animal variation was not responsible
for lack of detection of differential expression. The
spleen is an important immunological organ in the
chicken and has been successfully utilized to detect dif-
ferences in cytokine gene expression after immunization
Marek’s disease vaccines and DNA vaccines [30-34].
The selection of vaccination at 2 weeks of age has also
been successfully utilized to detect splenic expression
differences [31], with several other vaccination times
used successfully: day 18 of incubation, 1 day of age,
and 2 weeks of age with a 4 week booster [30,32-34].
The time period selected between immunization and
sampling can greatly impact the ability to detect expres-
sion differences, with later sampling times, 10 days post
vaccination, showing reduced expression differences
compared to earlier sampling times [31,33], though
detection 26 days post vaccination is still possible [34].
It is likely that the selection of 1 and 5 days post chal-
lenge, 15 and 20 days after initial vaccination, was not
optimal for expression discovery in the spleen utilizing
an Iss vaccine.
There were more DE genes in the NV-C severe group
than the V-C group on both days when contrasted
against NV-NC control. Analysis of host-pathogen inter-
action genes [34] and cytokines [30] in response to Mar-
ek’s Disease virus challenge revealed more DE genes in
Table 2 Number of GO biological terms found in each
contrast
Contrast DE
Genes
Biological
Terms
NV-C Mild Day 1 vs. NV-NC Control Day 1 29 2
NV-C Severe Day 1 vs. NV-NC Control Day
1
1101 27
NV-C Severe Day 5 vs. NV-NC Control Day
5
1723 73
V-C Day 1 vs. NV-NC Control Day 1 182 27
V-C Day 5 vs. NV-NC Control Day 5 137 1
NV-C Severe Day 1 vs. NV-C Severe Day 5 248 4
NV-C Severe Day 5 vs. NV-C Mild Day 5 799 63
Number of differentially expressed (DE) genes found between contrasts of
interest and the number of biological terms found using those genes.
Table 3 Quantitative PCR validation
Gene Contrast qPCR Microarray
AvBD
2
NV-C Severe Day 5 vs. NV-C Mild Day 5 -3.035* -2.038**
NV-C Severe Day 1 vs. NV-NC Control
Day 1
2.954** 1.552**
NV-
C Severe Day 5 vs. NV-NC Control Day 5
-3.206** -1.863**
NV-C Severe Day 1 vs. NV-C Severe Day
5
5.525** 2.931**
AvBD
6
NV-C Severe Day 1 vs. NV-NC Control
Day 1
2.592** 1.719**
NV-C Severe Day 1 vs. NV-C Severe Day
5
4.726** 2.194**
AvBD
7
NV-C Severe Day 5 vs. NV-C Mild Day 5 -4.259 -3.440**
NV-C Severe Day 1 vs. NV-NC Control
Day 1
1.214 1.731**
NV-C Severe Day 1 vs. NV-C Severe Day
5
4.446* 3.346**
IL1B NV-C Mild Day 1 vs. NV-NC Control Day
1
0.567 3.826**
NV-C Severe Day 1 vs. NV-NC Control
Day 1
1.290 1.836**
NV-C Severe Day 5 vs. NV-NC Control
Day 5
2.296 1.960**
IL6 NV-C Severe Day 5 vs. NV-C Mild Day 5 2.263 1.117**
NV-C Severe Day 1 vs. NV-NC Control
Day 1
3.027* 1.227**
NV-C Severe Day 5 vs. NV-NC Control
Day 5
2.611 1.138**
IFNG NV-C Severe Day 5 vs. NV-C Mild Day 5 2.399** 1.154**
NV-C Severe Day 5 vs. NV-NC Control
Day 5
2.427** 2.000**
TLR 2 NV-C Severe Day 1 vs. NV-NC Control
Day 1
-0.070 1.140**
NV-C Severe Day 5 vs. NV-NC Control
Day 5
0.699 0.984**
TLR 4 NV-C Severe Day 5 vs. NV-NC Control
Day 5
1.396* 1.336**
MD-2 NV-C Severe Day 5 vs. NV-C Mild Day 5 0.028 5.311**
NV-C Severe Day 5 vs. NV-NC Control
Day 5
0.034 1.230**
IL1-R,
type II
NV-C Severe Day 1 vs. NV-C Mild Day 1 1.574 ** 1.263**
NV-C Severe Day 1 vs. NV-NC Control
Day 1
1.241 2.676**
Log2 fold change between contrasts presented. + values indicate higher
expression in the first group, - values indicate higher expression in the second
group. ** P value < 0.05 in qPCR, q-value < 0.05 in microarray, * P value <
0.10 in qPCR
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This trend was again seen in birds challenged with Sal-
monella Enteritidis in the cecum of vaccinated and non-
vaccinated birds [35]. Non-vaccinated birds that receive
a pathogen challenge may rely more on significant
changes in gene regulation to fight off bacteria than vac-
cinated birds. The greater amount of DE genes detected
may also be attributed to the selection of average
lesioned birds for representatives of the V-C group,
though the number of DE genes is still a small fraction
of that generated by the severe group.
Effect of APEC challenge on splenic gene expression
varied with level of pathology. The contrasts in which
there were the largest numbers of DE genes involved
the NV-C severe group. Severe pathology may produce
the largest changes in gene expression levels making
them easier to detect, as observed with serum cytokine
levels [36]. The NV-C mild group varied little from the
NV-NC control, suggesting that the bacteria may have
been cleared and the bird returned to homeostasis by
day 5, while still exhibiting a small response on day 1.
In contrast, the number of DE genes increased from day
1t od a y5i nt h eN V - Cs e v e r eg r o u pc o m p a r e dt ot h e
NV-NC control. Past studies utilizing Salmonella and
two distinct genetic populations illustrated differences in
gene expression patterns between mild and severe
pathologies unique to a genetic background [37],
demonstrating the importance of assessing responses in
lines of interest, such as a commercial line used in this
study, for potential application. Commercial type birds,
broiler chickens and broiler × Leghorn chickens, noted
t h es a m ei n c r e a s ei ng e n ee x p r e s s i o no v e rt i m eu n d e r
severe pathology, while chickens with a more robust
chicken background, broiler × Fayoumi, had fewer DE
genes that decreased over time under severe pathology
[37]. Due to the clear difference in number of DE genes
seen between either NV-C mild or NV-C severe and the
NV-NC control group, it is unusual that there is not a
higher number of DE genes detected between the NV-C
mild and NV-C severe groups on day 1. Levels of serum
amyloid A and cytokines showed a linear trend between
control, mild, moderate and severe conditions [36]. This
suggests that this is the trend for splenic gene expres-
sion level between NV-NC control, NV-C mild and NV-
C severe groups. This intermediate expression could
make it more difficult to detect expression differences,
while the large expression level changes in the NV-C
severe group make it easy to detect them against NV-
NC control.
At both tissue harvest times, more genes increased
expression in challenged groups compared to NV-NC
control groups (55-78%) and more increased in severe
compared to mild pathology group on day 5 (66%). Bac-
terial challenge has been demonstrated to cause more
gene induction than repression [37], particularly within
cytokines [38]. Direction stayed consistent for genes that
were significant on both days. Of the genes that were
differentially expressed in NV-C severe compared to
NV-NC control on both days, 385 of 387 were in the
same direction of regulation and all 6 DE genes on both
days in the V-C groups were in the same direction of
regulation.
In generation of the heatmaps, genes included were
largely driven by the NV-C severe group, requiring a
minimum q-value of 0.05 across all contrasts included.
Comparing the change over time for each treatment
group (Figure 5), groups clustered as expected based on
earlier contrast comparisons. The NV-C mild pathology
group showed little difference compared to NV-NC con-
trol and also showed more similar expression pattern
c h a n g e st ot h eV - N Cg r o u pt h a nt ot h eN V - Cs e v e r e
and V-C group. As expected, both the NV-NC and the
V-NC groups exhibit minimal changes of 2 fold or
greater, further illustrating the lack of expression
changes over time without a pathogen stimulus. When
comparing each treatment with the NV-NC control
(Figure 6), the NV-C mild group on day 1 was most
similar to the other challenged groups, while on day 5 it
clustered with non-challenged groups, supporting the
hypothesis of returning to homeostasis, or a non-chal-
lenged state, by day 5. Contrasts that represented the
same day post challenged clustered together, demon-
strating strong similarities in expression changes over
time among groups.
Gene ontology investigation
The advantage of utilizing a global microarray is the
potential to investigate and discover a wide range of
gene ontology (GO) terms hidden within the dataset.
Although it is difficult to differentiate cause and effect
in gene expression in a pathogen challenge, functional
terms enriched in the biological processes may grant
some insights. Terms related to immune response, regu-
lation of immune related cells, and metabolic processes
commonly appeared in contrasts involving the NV-C
severe group on both days or V-C group on day 1, con-
sistent with bacterial infection as detected in multiple
tissues [39-42].
T h eN V - Cs e v e r eg r o u po nd a y1h a dm a n yt e r m s
related to response to bacteria, inflammation and circu-
latory processes, along with a few receptor signaling
terms. Particular genes among these groups included
the avian beta-defensins, known peptides with antimi-
crobial activity that have demonstrated induction pat-
terns in various tissues in response to E.coli derived
lipopolysaccharide and Salmonella [43-45]. Toll-like
receptors (TLR) recognize conserved molecular patterns
common to many pathogens. Changes in TLR
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Page 10 of 13expression, in response to bacterial infection, have also
been demonstrated [17,46]. Induction of pro-inflamma-
tory response after pathogen challenge is common [47].
The changes seen in inflammation and circulatory pro-
cesses may be responsible for observed lesion
phenotype.
At day 5, many of the terms found in the NV-C severe
group had changed, focusing more on regulation of
white blood cells, localization and transport, with lesser
emphasis on metabolic and biosynthetic processes than
day 1. The severe status of these birds may be attributed
to a slower response by these defense mechanisms.
Cytokines and chemokines help signal white blood cells
a n da t t r a c tt h e mt os i t e so fi n f e c t i o n .M a n yc y t o k i n e s
have reported expression differences in less than 5 days
post infection [42,48]. The main detectable differences
between NV-C mild and NV-C severe groups on day 5
involved response mechanism and regulation of WBC.
The Jak-STAT and cytokine-cytokine receptor interac-
tion pathways have several overlapping elements, 6 and
9 overlapping elements in contrasts of NV-C severe vs.
NV-C mild on day 5 and NV-C severe vs. NV-NC con-
trol on day 5 respectively. Bacterial infection has pre-
viously noted changes in the Jak-STAT pathway in
granulosa cells [40] and cecal tissue [39]. Changes in
genes in these pathways have also been discovered in
spleen after Clostridium infection: signal transducer and
activator of transcription, growth factor receptor-bound
protein, cytokines and cytokine receptor genes [42].
The low number of DE genes found between several
contrasts of interest limited GO analysis. Only one biolo-
gical process term was significantly enriched in two con-
trasts examined: intracellular signaling cascade, between
NV-C mild and NV-NC control groups on day 1 and
transcription, between V-C and NV-NC control on day
5. As with many current microarrays, annotation has lim-
ited the extent of GO analysis, illustrating the urgent
need to increase our knowledge in gene functions of gen-
ome sequences which have been discovered [49].
Conclusions
There is a large difference in splenic transcriptome pro-
f i l e sb e t w e e nb i r d sw i t hm i l da n ds e v e r el e s i o n si n
response to APEC infection, revealing gene networks
potentially associated with disease resistance. The
response of birds with severe lesions is much larger, both
in magnitude and number of differentially expressed
genes, than birds with mild lesions. Time post-challenge
with APEC also resulted in significant differences in gene
expression. Few differences were detected between the
NV-C mild group and NV-NC control at day 1 and zero
at day 5, suggesting that immune response to APEC was
very rapid, occurring before day 1 sampling, or involved
few detectable gene expression changes. Vaccination
generated an efficacious protective effect, but no expres-
sion differences were detected at 2 weeks post vaccina-
tion. The gene ontology terms found within uniquely
differentially expressed genes of birds with severe lesions
helped provide insight into what genes are different as
well as the overall processes defined by those genes.
Changes in the Jak-STAT pathway and cytokine-cytokine
receptor signaling highlight the importance of proper sig-
naling cascades to fight infection. The results from this
study add greater depth to the knowledge base about
chicken host response to APEC.
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